US-Listed Public Company Profile built from SEC and market records · June 2026

REVVITY, INC. (RVTY)

$160.39 +1.02% NYSE: RVTY · 15-min delayed

WALTHAM, Massachusetts
Public · NYSE: RVTY
11,000 employees

Visit website Follow

$12.3BMarket cap

$2.9BRevenue · FY2025

$241.2MNet income

11,000Employees

RVTYNYSE

1972IPO

About REVVITY, INC.

Revvity is a global life sciences and diagnostics company formed in 2023 following the rebranding of PerkinElmer. The company operates in two segments: life sciences, which provides reagents and instruments for biopharma and academic research, and signals software, and diagnostics, which offers tools in immunodiagnostics and newborn and reproductive health. Revvity's products and services are sold worldwide, with major markets in the US, Europe, and China.

This profile is unclaimed. An authorized representative can claim it free to control the page and activate the embeddable Verified badge.

Company facts

Type: Public · NYSE: RVTY
Employees: 11,000
IPO date: Jun 1, 1972
Headquarters: 77 4TH AVENUE
WALTHAM, Massachusetts 02451
Phone: 781-663-6900
Industry: Medical Devices
Website: Visit site

Incorporation record

Incorporated in: MA, United States
Registered office: Boston, US
Legal entity ID: 549300IKL1SDPFI7N655

Source: GLEIF, the global Legal Entity Identifier registry · checked Jul 26, 2026. A US headquarters does not always mean US incorporation.

Registry IDs

Ticker: RVTY NYSE
SEC CIK: 31791
LEI: 549300IKL1SDPFI7N655
EIN: 042052042
SIC: 3826 LABORATORY ANALYTICAL INSTRUMENTS

Explore our data studies: the biggest company in every US state · all rankings & reports.

Embed this company’s badge

Show Revvity, Inc.’s American-company profile badge on a website — copy this HTML:

<a href="https://americancompanies.com/company/revvity-inc/"><img src="https://americancompanies.com/badge/revvity-inc.svg" alt="Revvity, Inc. — American company profile on americancompanies.com" width="220"></a>

Is this your company?

This profile is unclaimed — any authorized owner can claim it free, control the page, and activate the embeddable Verified badge for their own website.

Claim this profile — free

Track American companies

Create a free account to follow REVVITY, INC. and get an email when it moves sharply — real market data, 15-minute delayed.

Create free account

Reported figures

Financial summary

Revenue FY2025: $2.9B
Net income: $241.2M
Total assets: $12.2B
Market cap: $12.3B

Source: SEC EDGAR · updated Jun 7, 2026

NYSE: RVTY

$160.39 +1.02%

15-minute delayed · data by Polygon.io

Past year · hover for prices

$82.26 $160.39

52-week range

Market cap: $12.3B
Dividend yield: 0.17%
Shares outstanding: 76.8M
Open: —
Day range: –
Prev close: —
Volume: —
IPO date: Jun 1, 1972

Revvity, Inc. (RVTY) Stock Price

Profitable — net income of $241.2M in FY2025.
Trading near its 52-week high.
Pays a dividend yielding about 0.17% annually.

Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.

Peers & competitors

THERMO FISHER SCIENTIFIC INC.TMO

AGILENT TECHNOLOGIES, INC.A

WATERS CORP /DE/WAT

BRUKER CORPBRKR

METTLER TOLEDO INTERNATIONAL INC/MTD

BIO-TECHNE CorpTECH

No reviews yet. Be the first to review REVVITY, INC..

Write a review

Newsroom

News about REVVITY, INC.

CareDx to Report Q3 Earnings: Transplant Testing Growth in Focus Zacks Investment Research · 2026-10-26 · positive ELV vs. RVTY: Which Stock Is the Better Value Option? Zacks Investment Research · 2026-10-23 · neutral Here's How IDEXX Laboratories Is Placed Ahead of Q3 Earnings Zacks Investment Research · 2026-10-23 · positive Revvity Launches Signals LabGistics to Coordinate Scientific Workflows Zacks Investment Research · 2026-10-22 · positive Thermo Fisher to Report Q3 Earnings: What's in the Cards? Zacks Investment Research · 2026-10-13 · positive Revvity (RVTY) Upgraded to Buy: What Does It Mean for the Stock? Zacks Investment Research · 2026-10-02 · positive

News & sentiment via Polygon.io

FAQ

Revvity, Inc.: frequently asked questions

Is Revvity, Inc. an American company?

Yes — Revvity, Inc. is an American company headquartered in Waltham, Massachusetts. Its American-origin credentials have been independently reviewed and verified by americancompanies.com.

Where is Revvity, Inc. headquartered?

Revvity, Inc. is headquartered in Waltham, Massachusetts, United States.

Is Revvity, Inc. publicly traded?

Yes — Revvity, Inc. is a publicly traded company. Its stock trades under the ticker symbol RVTY on the NYSE.

What does Revvity, Inc. do?

Revvity, Inc. is an American Medical Devices company in the Health & Beauty sector.

Explore